Package 0517-2901-01

{"route": ["INTRAVENOUS"], "spl_id": "394a5780-8ead-4c26-890c-37edfb879599", "openfda": {"nui": ["N0000190852", "N0000190853", "N0000009340", "N0000009345", "N0000008636", "N0000008635", "N0000008652"], "unii": ["76LA80IG2G"], "rxcui": ["2587358", "2587361"], "spl_set_id": ["359982a8-ec5c-4927-8c0f-89771e0f942b"], "pharm_class_pe": ["Increased Gluconeogenesis [PE]", "Increased Glycogenolysis [PE]", "Decreased GI Smooth Muscle Tone [PE]", "Decreased GI Motility [PE]", "Decreased Glycolysis [PE]"], "pharm_class_epc": ["Antihypoglycemic Agent [EPC]", "Gastrointestinal Motility Inhibitor [EPC]"], "manufacturer_name": ["American Regent, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (0517-2901-01)  / .2 mL in 1 VIAL", "package_ndc": "0517-2901-01", "marketing_start_date": "20250819"}, {"sample": false, "description": "10 VIAL in 1 CARTON (0517-2901-10)  / .2 mL in 1 VIAL", "package_ndc": "0517-2901-10", "marketing_start_date": "20250819"}], "brand_name": "Gvoke VialDx", "product_id": "0517-2901_394a5780-8ead-4c26-890c-37edfb879599", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Antihypoglycemic Agent [EPC]", "Decreased GI Motility [PE]", "Decreased GI Smooth Muscle Tone [PE]", "Decreased Glycolysis [PE]", "Gastrointestinal Motility Inhibitor [EPC]", "Increased Gluconeogenesis [PE]", "Increased Glycogenolysis [PE]"], "product_ndc": "0517-2901", "generic_name": "glucagon injection", "labeler_name": "American Regent, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Gvoke VialDx", "active_ingredients": [{"name": "GLUCAGON", "strength": "1 mg/.2mL"}], "application_number": "NDA212097", "marketing_category": "NDA", "marketing_start_date": "20250819", "listing_expiration_date": "20261231"}